BGNE Teams Up With Novartis, Editas Slumps Over 15%, Eli Lilly’s Drug Shines In TRAILBLAZER-ALZ, Mesoblast On Watch
BASEL (dpa-AFX) – Today’s Daily Dose brings you news about Lilly’s Alzheimer’s disease trial data, BeiGene’s collaboration agreement with Novartis, Mesoblast’s encouraging results from phase III t… FinanzNachrichten.de: Meistgelesene Nachrichten
